Encéphalite limbique à anticorps anti-LGI1 révélée par une crise généralisée inaugurale

Dalmau, 2008, Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies, Lancet Neurol, 7, 1091, 10.1016/S1474-4422(08)70224-2 Anderson, 2008, Limbic encephilitis — A review, J Clin Neurosci, 15, 961, 10.1016/j.jocn.2007.12.003 Asztely, 2012, The diagnostic and treatment of limbic encephilitis, Acta Neurol Scand, 126, 365, 10.1111/j.1600-0404.2012.01691.x Lai, 2010, Investigation of LGI-1 as the antigen in limbic encephalitis previously attribuated to potassium channels: a case series, Lancet Neurol, 9, 776, 10.1016/S1474-4422(10)70137-X Van Sonderen, 2016, Anti-LGI1 encephalitis clinical syndrome and long-term follow-up, Neurology, 87, 1449, 10.1212/WNL.0000000000003173 Van Sonderen, 2016, From VGKC to LGI1 and Caspr2 encephalitis: the evolution of a disease entity over time, Autoimmun Rev, 15, 970, 10.1016/j.autrev.2016.07.018 Irani, 2013, Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype, Brain, 136, 3151, 10.1093/brain/awt212 Kim, 2016, Capability of arterial spin labeling MR imaging in localizing seizure focus in clinical seizure activity, Eur J Radiol, 85, 1295, 10.1016/j.ejrad.2016.04.015 Vincent, 2004, Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis, Brain, 127, 701, 10.1093/brain/awh077 Lancaster, 2016, The diagnosis and treatment of autoimmune encephalitis, J Clin Neurol, 12, 1, 10.3988/jcn.2016.12.1.1 Bataller, 2007, Autoimmune limbic encephilitis in 39 patients: immunophenotypes and outcomes, J Neurol Neurosurg Psychiatry, 78, 381, 10.1136/jnnp.2006.100644 Ariño, 2016, Anti-LGI1-associated cognitive impairment: presentation and long-term outcome, Neurology, 87, 759, 10.1212/WNL.0000000000003009